Results 181 to 190 of about 39,639 (239)

Evaluating the Serum Levels of CD73 in Patients with Head and Neck Squamous Cell Carcinoma. [PDF]

open access: yesJ Dent (Shiraz)
Zare R   +5 more
europepmc   +1 more source

Engineering an AIEgen-based platform integrating CRISPR/Cas9 to remodel the tumor microenvironment and reinforce photo-immunotherapy against glioblastom. [PDF]

open access: yesSignal Transduct Target Ther
Luo G   +11 more
europepmc   +1 more source

AC3<sup>®</sup> exerts cytotoxic and anti-migratory activity and modulates the gene expression of TNF-α, inflammatory mediators, and components of the CD39/CD73/adenosine axis in cutaneous melanoma cell lines. [PDF]

open access: yesMed Oncol
Manica D   +11 more
europepmc   +1 more source

CD4+ T Cells Sensitize Quasimesenchymal Breast Tumors Lacking CD73 to Anti-CTLA4 Immune Checkpoint Blockade Therapy. [PDF]

open access: yesCancer Res Commun
Chandraganti S   +16 more
europepmc   +1 more source

Calcitriol, the active form of vitamin D, induces cell death and purinergic signaling modulation in cutaneous melanoma cells. [PDF]

open access: yesMed Oncol
da Silva GB   +7 more
europepmc   +1 more source

Rag1-based time-stamp tracing of T-cell developmental origins. [PDF]

open access: yesJ Immunol
Jiang M   +11 more
europepmc   +1 more source

Two differentiation pathways generate large peritoneal macrophages with one replenishing mesothelial border macrophages. [PDF]

open access: yesSci Immunol
Han J   +19 more
europepmc   +1 more source

Purinergic activity of circulating extracellular vesicles associates with disease progression in melanoma. [PDF]

open access: yesOncoimmunology
Najjar YG   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy